A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody-Reference-Cited by-同舟云学术

A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody

Published:2013-05-20 Issue:12 Volume:190 Page:6239-6249
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Abe Shinji,Morita Yuki,Kaneko Mika Kato,Hanibuchi Masaki,Tsujimoto Yuta,Goto Hisatsugu,Kakiuchi Soji,Aono Yoshinori,Huang Jun,Sato Seidai,Kishuku Masatoshi,Taniguchi Yuki,Azuma Mami,Kawazoe Kazuyoshi,Sekido Yoshitaka,Yano Seiji,Akiyama Shin-ichi,Sone Saburo,Minakuchi Kazuo,Kato Yukinari,Nishioka Yasuhiko

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference53 articles.

1. Advances in Malignant Mesothelioma

2. The Mesothelioma epidemic in Western Europe: an update

3. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model

4. Malignant Pleural Mesothelioma

5. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models;Cancers;2023-10-20

2. Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C44Mab-108 for Immunohistochemistry;Current Issues in Molecular Biology;2023-02-25

3. Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2022-08-01

4. Development of a Monoclonal Antibody PMab-295 Against Elephant Podoplanin;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2022-08-01

5. The Role of Podoplanin in the Immune System and Inflammation;Journal of Inflammation Research;2022-06